I Love BrainsBY AUGMENTA HEALTH

All chapters / Chapter 16

Treatment · 12 sections

Psychopharmacology

Dr. Mohan Sunil Kumar · Original companion content, reformatted for reading

Legacy notes · Clinical update review pending. Original wording is preserved; this is not a newly revised 2026 edition.
Original player ↗
SECTION 01

Basics of Psychopharmacology

Check out this video on tolerance @ https://youtu.be/Q9Lc6c0LxXY

Check out this video on A to Z tips related to Psychopharmacology @ https://youtu.be/U0D3wIwEJrI

SECTION 02

SSRIs

SSRI = Selective serotonin reuptake inhibitor.

List of common SSRIs:

  • Escitalopram
  • Citalopram
  • Sertraline
  • Fluoxetine
  • Fluvoxamine
  • Paroxetine

Did you know?

  • SSRIs can occasionally cause gastro-intestinal bleeds
  • SSRIs are used as treatment for premature ejaculation, as SSRIs have an adverse effect of delaying ejaculation
  • SSRIs can be used for prophylaxis in chronic headache, as well as it can cause headache as a side effect

SSRIs and risk of abnormal bleeding:

  • Upper GI is the commonest site of abnormal bleeding
  • Concomitant use of anticoagulants and antiplatelet drugs INCREASES the risk
  • Concomitant use of antacids DECREASES the risk
  • Possible mechanism:
  • Decreased serotonin reuptake into the platelets. Increased expression of Glycogen Synthase Kinase - 3 - beta (GSK3B) on platelets, and Interaction with the surface lIb/lIla receptors.
SECTION 03

Newer drugs

Vilazodone:

Check out an explanatory video on this molecule @ https://youtu.be/R12aB4X7-Zk

SECTION 04

Atypical antipsychotics

The atypical nature of atypical antipsychotics is:

  • They act on serotonin as well on dopamine receptors
  •  They bind to lesser percentage of dopamine receptors, or the binding is reversible or intermittent
  • They do have lesser chances or causing extrapyramidal side effects

List of common atypical antipsychotics are:

  • Clozapine
  • Risperidone
  • Olanzapine
  • Quetiapine
  • Aripiprazole
  • Ziprasidone
  • Amisulpride
  • Levosulpiride

Important side effects related to specific atypical antipsyhotics:

  • Cataract - Quetiapine
  • CVA - Risperidone, Olanzapine
  • Hyperprolactinemia - Risperidone, Paliperidone, and Amisupiride
  • Cardiotoxicity - Ziprasidone
  • Agranulocytosis and myocarditis - Clozapine

List of weight neutral atypical antipsychotics:

  • Ziprasidone
  • Aripiprazole
  • Amisulpiride

Important side effects with Clozapine:

  • Hypeyglycemia
  • Weight gain
  • Sedation
  • Dyslipidemia
  • Agranulocytosis (0.8 - 1.2% on Clozapine, Prophylactic weekly blood test to screen is done for early identification)
  • Myocarditis
  • Sialorrhoea
  • Decrease in seizure threshold

SECTION 05

Depot antipsychotic preperations

Typical anitpsychotics available in depot formulations:

  • Haloperidol
  • Flupenthixol
  • Zulcopenthixol
  • Fluphenazine

Atypical antipsychotics available in depot formulations:

  • Risperidone
  • Paliperidone
  • Olanzapine
  • Aripiprazole
SECTION 06

Dystonia

Dystonia:

The risk factors for developing Dystonia are:

  • Young
  • Muscular
  • Male
  • Mood disorder
  • Family history or past history of dystonia
  • Black race
  • Cocaine use
  • Hypocalcemia
  • Hypoparathyroidism
  • Hyperthyroidism
  • Dehydration

Note:
The three types of truncal dystonia are:
1. Opisthotonus - Backward flexion
2. Camptocormia - Anterior flexion
3. Pleurothotonus (PISA SYNDROME) - Lateral flexion

SECTION 07

Tardive Dyskinesia (TD)

Important risk factors for TD are:
Increasing age
Elderly female
Mood disorder patients
Higher dosage and longer duration of medication (higher cumulative dosage)
Concomittant medication
Diabetes
Cognitive and thought dysfunction
Substance use disorders
Negative symptoms

Note:
Periporal tremors is also called as Rabbit syndrome.

SECTION 08

Akathisia

Akathisia (in greek means ‘inability to sit) is a common acute extrapyramidal side effect following exposure to antipsychotic. It occurs within 7—10 days of antipsychotic exposure, characterized by state of inner restlessness and shifting of weight. 

Clinically, the patients with akathisia are commonly noticed to keep shining their weight from one leg to another and pacing around with marked mental distress. Heightened lower limb movements are characteristic of the condition. 

First generation older antipsychotics have higher chance of producing akathisia compared to second generation antipsychotics. Among the second generation antipsychotics,clozapine has the least and aripiprazole has the highest chance of causing akathisia.

Akathisia is a risk factor for non-compliance with medications and are known to increase the risk or suicide. 

Risk factors to develop Akathisia:

  • Increasing age
  • Female
  • Mood disorders
  • Negative symptoms
  • Cognitive dysfunction
  • Iron deficiency
  • Prior akathisia
  • Concomitant parkinsonism

Management of Akathisia includes:
Reducing the antipsychotic dosage if possible is the preferred first step
Changeover to another antipsychotic with lesser potential to cause Akathisia.

Use of pharmacological agents like:
Diazepam
Trihexiphenidyl
Propranolol

SECTION 09

Neuroleptic Malignant Syndrome (NMS)

It is an idiopathic and idiosyncratic acute extrapyramidal adverse effect, occurring following the exposure to an antipsychotic in some susceptible individuals. 

Clinical triad of NMS:
- Lead pipe rigidity (severe extrapyramidal rigidity) ‘Autonomic dysfunction
- Altered sensorium
- Fever or hyperthermia

Some of the factors which could suggest possibility of occurrence of NMS are:
Muscular males
Dehydration and exhaustion
Typical antipsychotics
Depot preparations
Rapid up-titration of antipsychotics
Agitated patients
Catatonia
Typical and high potency antipsychotics
Depot preparations
Rapid up-titration of antipsychotics
Previous history of NMS

Laboratory findings include:
Raised CPK levels
Elevated total WBC count
Myoglobinuria

The various drugs and modes useful in the management of NMS are:
Bromocriptine
Amantadine
Dantrolene (Drug of choice for Mx of NMS)
Electroconvulsive therapy (ECT)

SECTION 10

Serotonin syndrome

It is the hypersensitivity of the serotonin receptors, 5HT1A and 5HT2A. It is commonly seen in patients on SSRIs or MAO inhibitors or other serotonergic drugs in combination or in isolation. 

Many times, SS is predictable as it happens when there is upward titration or introduction of another serotonergic drugs; especially working in different modes of action.

The symptoms are part of three main domains of presentation:
Psychic symptoms: Confusion. hyperactivity, agitation. insomnia, restlessness. and coma.
Autonomic symptoms: Hyperthermia. diaphoresis, tachycardia, flushing, and diarrhoea.
Neuromuscular symptoms: Hypertonia. clonus. myoclonic jerks, hyperreflexia and tremors.

Common individual drugs and combinations precipitating SS are:
Selective Serotonin Reuptake Inhibitors (SSRIs)
MAO inhibitors
Amphetamines
Lithium
Tramadol
Clomipramine
Sumatriptan

Post stopping the culprit drug(s). SS is self remitting and recovery is the norm. Mortality increases with severe symptoms. misdiagnosis, rhabdomyolysis, disseminated intravascular coagulation and adult respiratory distress syndrome. 

Drugs which can be used as antagonist ¡f necessary are Cyproheptadine and Chlorpromazine.

SECTION 11

TCA poisoning

Tricyclic antidepressants (TCAs) overdose possibly occurs as accidental or deliberate overdose.

The clinical presentation with TCA toxicity are:
• Cardiotoxicity
• Hypotension
• Tachycardia
• Decreased sweating
• Dryness of mouth
• Seizures
• Metabolic acidosis

Treatment – Intravenous Sodium Bicarbonate

SECTION 12

Lithium toxicity

Lithium levels > 1.5 mEq/L

The factors that can precipitate toxicity of Lithium are:
• During initiation and dose titration
• Self-administration of higher doses (Intentional/accidental)
• Dehydration
• Hyponatremia
• Concomitant use of NSAID5. ACE Inhibitors, id Diuretics Features of lithium toxicity

Features of Lithium toxicity:
• Myoclonic jerks
• Delirium
• Coarse tremors
• Urinary incontinence
• Seizures
• Ataxia
• Nystagmus
• Coma
• Death
• Hyperreflexia
• Rigidity

Treating Lithium toxicity is by the following measures:
1. Stoppage of lithium.
2. Ensure adequate hydration and stabilization of vital signs.
3. Stop concomitant medications which could be increasing lithium levels . Encourage oral fluids or intravenous fluid infusion, as necessary.
4. Use loop diuretics (Furosemide or Amiloride).
5. Intracorporeal management: Adsorbants can be used to decrease further absorption of lithium from stomach - activated charcoal or Whole bowel irrigation (WBI)/
6. Extracorporeal management in the form of hemodialysis (hemofiltration) or enteraI treatments like use of sodium polystyrene sulphate (SPS).